Entresto, a New Panacea for Heart Failure?-Reference-Cited by-同舟云学术

Entresto, a New Panacea for Heart Failure?

Published:2018-09-10 Issue:1 Volume:16 Page:5-11
ISSN:1871-5257
Container-title:Cardiovascular & Hematological Agents in Medicinal Chemistry
language:en
Short-container-title:CHAMC

Author:

Khalil Peter¹,Kabbach Ghazal¹,Said Sarmad²,Mukherjee Debabrata²

Affiliation:

1. Department of Internal Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX, United States

2. Department of Internal Medicine, Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, TX, United States

Publisher

Bentham Science Publishers Ltd.

Subject

Cardiology and Cardiovascular Medicine,Pharmacology,Hematology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioanalytical HPLC method with fluorescence detector for determination of Entresto™ when co-administered with ibuprofen and fexofenadine: a pharmacokinetic study;RSC Advances;2024

2. Discovery of effective combination from Renshen-Fuzi herbal pair against heart failure by spectrum-effect relationship analysis and zebrafish models;Journal of Ethnopharmacology;2023-12

3. The role of Zn2+ in shaping intracellular Ca2+ dynamics in the heart;Journal of General Physiology;2023-06-16

4. A study of the efficacy of sacubitril/valsartan plus dapagliflozin combination treatment in pulmonary arterial hypertension due to left heart disease;Perfusion;2022-09-29

5. Drug–Drug Multicomponent Crystals of Epalrestat: A Novel Form of the Drug Combination and Improved Solubility and Photostability of Epalrestat;Crystal Growth & Design;2022-07-11